pipette
ESEspañol

Targeting SUV39H2 exon skipping reverses resistance to CDK4/6 inhibitors via transcriptional activation of p21

Shiyi Yu, Xue Qin Gong, Yawen Yang, Ying Duan, Siyu Zhang, Ying Wang, Zheng Wang, Caili Bi, Haibo Sun

Peer-reviewed journalReal-world use

In the authors' words

This journal does not let us republish the full abstract. Here are the two sentences Pipette selected, quoted from it. Read the rest at the publisher.

Main result
Our work unveils a splicing-mediated resistance mechanism and presents a potential synergistic drug target for CDK4/6i therapy.

Appeared: Sunday, October 11. Science Advances. Peer-reviewed journal.

DOI: 10.1126/sciadv.aea2001